JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Characteristics
Peer reviewed
Abstract
Harmala alkaloids have attracted the interest of many investigators on account of their effect on the extrapyramidal system, their hallucinogenic properties, their inhibitory activity on monoamine oxidase and the hypothetical role of related compounds in mental illness. [...]
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
Mitochondrial dysfunction and biotransformation of β-carboline alkaloids, harmine and harmaline, on isolated rat hepatocytes.
Chemico-Biological Interactions
September 15, 2010
Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.
Pharmacological Reports
June 1, 2016
13 citations
Effects of the Naturalβ-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies
Journal of Psychoactive Drugs
December 5, 2016
64 citations
Interaction of beta-carbolines with central dopaminergic transmission in mice: structure-activity relationships.
Neuroscience Letters
April 14, 1995
beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
March 1, 2010
For research and education, not medical advice. Talk with a clinician about your own care.
© 2026 The Consciousness Library
Support Our Mission
Choose your preferred way to support The Consciousness Library's work in advancing consciousness research.
A registered 501(c)(3) nonprofit; donations are tax-deductible in the US.
Donations are processed by Mindscape Collective, our legal entity, and may appear that way on your statement.